Citation | Barlind, JG; Bauer, UA; Birch, AM; Birtles, S; Buckett, LK; Butlin, RJ; Davies, RD; Eriksson, JW; Hammond, CD; Hovland, R; Johannesson, P; Johansson, MJ; Kemmitt, PD; Lindmark, BT; Morentin Gutierrez, P; Noeske, TA; Nordin, A; O'Donnell, CJ; Petersson, AU; Redzic, A; Turnbull, AV; Vinblad, J Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem55:10610-29 (2012) [PubMed] Article |
---|
SMILES | CC(C)(NC(=O)C[C@H]1CC[C@@H](CC1)c1ccc(cc1)-c1cncc(n1)C(N)=O)C(O)=O |r,wU:10.13,wD:7.6,(75.46,-31.72,;76.24,-30.39,;77,-31.72,;74.9,-29.62,;73.57,-30.39,;73.57,-31.93,;72.24,-29.62,;70.9,-30.39,;69.57,-29.62,;68.23,-30.39,;68.24,-31.93,;69.57,-32.7,;70.9,-31.93,;66.9,-32.7,;66.91,-34.25,;65.57,-35.02,;64.24,-34.25,;64.24,-32.71,;65.57,-31.93,;62.91,-35.02,;62.91,-36.55,;61.58,-37.32,;60.24,-36.55,;60.24,-35.01,;61.57,-34.24,;58.91,-34.24,;57.57,-35.01,;58.91,-32.7,;77.57,-29.62,;78.91,-30.39,;77.57,-28.08,)| |